Biocryst Pharmaceuticals Inc.
NASDAQ:BCRX 3:59:57 PM EDT
| Market Cap (Intraday) | 2.14B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $11.30 |
| 50-Day MA | $11.18 |
| 200-Day MA | $6.89 |
Biocryst Pharmaceuticals Inc. Stock, NASDAQ:BCRX
4505 Emperor Boulevard, Suite 200, Durham, North Carolina 27703-8457
United States of America
Phone: +1.919.859.1302
Number of Employees: 246
Description
BioCryst Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the development and discovery of novel, oral, and small-molecule medicines. It focuses on the oral treatments for rare diseases in which significant unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. The company was founded in 1986 and is headquartered in Durham, NC.